Brexanolone
Back to searchMolecule Structure
Scientific Name
Brexanolone
Description of the Drug
Not Available
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB11859
http://www.drugbank.ca/drugs/DB11859
Brand Name(s)
Zulresso
Company Owner(s)
Sage Therapeutics Inc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | POSITIVE ALLOSTERIC MODULATOR | CHEMBL2093872 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL588060 | ||||||||
| Human Metabolome Database | HMDB0001449 | ||||||||
| DrugBank | DB11859 | ||||||||
| PubChem: Thomson Pharma | 14826064 | 14923739 | |||||||
| PubChem | 92786 | ||||||||
| NMRShiftDB | 60020580 | ||||||||
| LINCS | LSM-19998 | ||||||||
| Nikkaji | J6.315K | ||||||||
| BindingDB | 50191342 | ||||||||
| EPA CompTox Dashboard | DTXSID1046342 | ||||||||
| LipidMaps | LMST02030130 | ||||||||
| Metabolights | MTBLC50169 | ||||||||
| Brenda | 5704 | 3984 | 8011 | 243285 | 219405 | 48735 | 37597 | 114602 | 138693 |
| Rhea | 50169 | ||||||||
| ChemicalBook | CB5418550 | ||||||||
| Guide to Pharmacology | 4108 | ||||||||
| SwissLipids | SLM:000485381 | ||||||||
| rxnorm | BREXANOLONE | ZULRESSO | |||||||
| PubChem: Drugs of the Future | 87550959 | ||||||||
| KEGG Ligand | C13712 | ||||||||
| ChEBI | 50169 | ||||||||
| ZINC | ZINC000004081043 |
